China Pharma Holdings, Inc. to Present at Two Upcoming Investor Conferences

Wednesday, November 28, 2007 General News J E 4
HAIKOU, Hainan, China, Nov. 27 ChinaPharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) todayannounced that Mr. Xinhua Wu, CFO of China Pharma, and Mr. Ren Zhang, VicePresident of China Pharma, will present at ROTH China -- Phoenix Conferenceand Annual ICR XChange Asia institutional investor conference.

Mr. Ren Zhang, Vice President of China Pharma, will present at the ROTHChina -- Phoenix Conference from 8:00 a.m. to 8:45 a.m. November 30, 2007 atthe Royal Palms Resort and Spa, 5200 East Camelback Road, Phoenix, Arizona.The presentation will be broadcast live over the Internet and can be accessedby all interested parties at China Pharma's website at . Management will host several break-outsessions with investors on both Nov 29th and 30th. For more information aboutthe conference, please visit .

Mr. Ren Zhang, Vice President, will present at the Annual ICR XChange Asiainstitutional investor conference at 1:30 p.m. ET December 5, 2007 at theReuters Conference Center at Three Times Square in New York City. Thepresentation will be webcast live at . Managementwill host two break-out sessions with investors the same day. For moreinformation, please visit .

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets genericand brand bio-pharmaceutical products in China that treat a wide range ofconditions, including infections, hepatitis, cardiovascular and CNS diseases,and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson),a specialty pharmaceutical company headquartered in Haikou City, Hainanprovince in China, is a wholly owned subsidiary of China Pharma Holdings.For more information, please contact: Sophia Yu China Pharma Holdings, Inc. Tel: +86-898-6681-1730 Email:

SOURCE China Pharma Holdings, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Vanda Pharmaceuticals Receives FDA Acceptance of I...
Anpath Group, Inc. Announces Introduction Of Equin...